The prognostic potential of long noncoding RNA XIST in cardiovascular diseases: a review.
Habib HaybarEhsan SarbazjodaDaryush PurrahmanMohammad-Reza Mahmoudian-SaniNajmaldin SakiPublished in: Personalized medicine (2024)
There is a significant mortality rate associated with cardiovascular disease despite advances in treatment. long Non-coding RNAs (lncRNAs) play a critical role in many biological processes and their dysregulation is associated with a wide range of diseases in which their downstream pathways are disrupted. A lncRNA X-inactive specific transcript (XIST) is well known as a factor that regulates the physiological process of chromosome dosage compensation for females. According to recent studies, lncRNA XIST is involved in a variety of cellular processes, including apoptosis, proliferation, invasion, metastasis, oxidative stress and inflammation, through molecular networks with microRNAs and their downstream targets in neoplastic and non-neoplastic diseases. Because these cellular processes play a role in the pathogenesis of cardiovascular diseases, we aim to investigate the role that lncRNA XIST plays in this process. Additionally, we wish to determine whether it is a prognostic factor or a potential therapeutic target in these diseases.
Keyphrases
- long noncoding rna
- cardiovascular disease
- long non coding rna
- oxidative stress
- prognostic factors
- poor prognosis
- cardiovascular events
- type diabetes
- cardiovascular risk factors
- diabetic rats
- dna damage
- induced apoptosis
- endoplasmic reticulum stress
- ischemia reperfusion injury
- risk assessment
- metabolic syndrome
- gene expression
- climate change
- cell death
- resting state
- rna seq
- dna methylation
- copy number
- replacement therapy
- heat shock
- functional connectivity